Physician

Gregory B Hoang, MD

According to 2025 Medicare claims, Gregory Hoang, MD (NPI: 1952362816) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is CANCER CARE CENTERS OF BREVARD INC (NPI: 1467551762; TIN: 593169766) and primary practice location at 32909-2200. Hoang is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Hoang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 441 traditional Medicare patients, billed 172,443 HCPCS/CPT codes, and received $1,841,640 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,280 prescription claims across 321 beneficiaries totaling $4,548,152 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 12 claims. Open Payments data shows 222 records totaling $6,236. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,286,826 and ending at $1,841,640. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $586,573 to $4,548,152. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $4,409 to $850.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	554	123,818	$1,286,826
2016	633	170,049	$1,765,816
2017	535	193,816	$2,261,170
2018	604	199,343	$3,033,264
2019	632	175,275	$2,252,287
2020	467	190,357	$3,038,065
2021	543	192,281	$3,248,869
2022	547	188,406	$2,700,269
2023	488	174,086	$2,753,814
2024	441	172,443	$1,841,640

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	134	745	$586,573
2016	148	866	$844,111
2017	155	969	$755,207
2018	174	1,065	$1,176,803
2019	205	1,236	$2,339,772
2020	232	1,528	$2,672,872
2021	251	1,880	$2,943,698
2022	270	1,985	$3,352,402
2023	291	2,128	$2,711,598
2024	321	2,280	$4,548,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	48	$4,409
2016	N/R	231	$111,980
2017	N/R	122	$66,681
2018	N/R	12	$3,949
2019	N/R	N/R	N/R
2020	N/R	83	$5,667
2021	N/R	143	$15,515
2022	N/R	86	$11,326
2023	N/R	11	$812
2024	N/R	12	$835

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	77	77	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	521	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	229	384	$69
36415	Insertion of needle into vein for collection of blood sample	138	323	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	150	493	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	50	1,400	$1,164,112
Jakafi	Ruxolitinib Phosphate	25	750	$418,600
Xtandi	Enzalutamide	30	900	$412,596
Lenalidomide	Lenalidomide	36	847	$400,368
Brukinsa	Zanubrutinib	19	570	$283,572

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$835

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	222	$6,236	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory B. Hoang, MD?

Tedicare shows public-source Medicare data for Gregory B. Hoang, MD (NPI 1952362816), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory B. Hoang, MD have ACO affiliation data?

Gregory B. Hoang, MD is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Gregory B. Hoang, MD?

Gregory B. Hoang, MD is linked to CANCER CARE CENTERS OF BREVARD INC (billing NPI 1467551762) in the available physician profile data.

Does Gregory B. Hoang, MD have Open Payments data?

Gregory B. Hoang, MD has 222 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.